{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T09:37:53Z","timestamp":1793525873110,"version":"4.5.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG055784"],"award-info":[{"award-number":["AG055784"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG15379"],"award-info":[{"award-number":["AG15379"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007625","name":"Cure Alzheimer's Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"DOI":"10.1186\/s40478-024-01876-y","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T05:02:23Z","timestamp":1729486943000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["PS1\/gamma-secretase acts as rogue chaperone of glutamate transporter EAAT2\/GLT-1 in Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"12","author":[{"given":"Florian","family":"Perrin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren C.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane P. C.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliia","family":"Turchyna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Maesako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei C. Q.","family":"Houser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven L.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolph E.","family":"Tanzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana","family":"Berezovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,21]]},"reference":[{"key":"1876_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/1098-1136(200010)32:1<1::AID-GLIA10>3.0.CO;2-W","volume":"32","author":"CM Anderson","year":"2000","unstructured":"Anderson CM, Swanson RA (2000) Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 32:1\u201314","journal-title":"Glia"},{"key":"1876_CR2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.nbd.2015.06.013","volume":"84","author":"M Arimon","year":"2015","unstructured":"Arimon M, Takeda S, Post KL, Svirsky S, Hyman BT, Berezovska O (2015) Oxidative stress and lipid peroxidation are upstream of amyloid pathology. Neurobiol Dis 84:109\u2013119. https:\/\/doi.org\/10.1016\/j.nbd.2015.06.013","journal-title":"Neurobiol Dis"},{"key":"1876_CR3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1460-9568.2007.05986.x","volume":"27","author":"M Bassan","year":"2008","unstructured":"Bassan M, Liu H, Madsen KL, Armsen W, Zhou J, Desilva T, Chen W, Paradise A, Brasch MA, Staudinger J et al (2008) Interaction between the glutamate transporter GLT1b and the synaptic PDZ domain protein PICK1. Eur J Neurosci 27:66\u201382. https:\/\/doi.org\/10.1111\/j.1460-9568.2007.05986.x","journal-title":"Eur J Neurosci"},{"key":"1876_CR4","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1021\/cr900343z","volume":"110","author":"MY Berezin","year":"2010","unstructured":"Berezin MY, Achilefu S (2010) Fluorescence lifetime measurements and biological imaging. Chem Rev 110:2641\u20132684. https:\/\/doi.org\/10.1021\/cr900343z","journal-title":"Chem Rev"},{"key":"1876_CR5","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1523\/jneurosci.0364-05.2005","volume":"25","author":"O Berezovska","year":"2005","unstructured":"Berezovska O, Lleo A, Herl LD, Frosch MP, Stern EA, Bacskai BJ, Hyman BT (2005) Familial Alzheimer\u2019s disease presenilin 1 mutations cause alterations in the conformation of presenilin and interactions with amyloid precursor protein. J Neurosci 25:3009\u20133017. https:\/\/doi.org\/10.1523\/jneurosci.0364-05.2005","journal-title":"J Neurosci"},{"key":"1876_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/cne.1128","volume":"433","author":"UV Berger","year":"2001","unstructured":"Berger UV, Hediger MA (2001) Differential distribution of the glutamate transporters GLT-1 and GLAST in tanycytes of the third ventricle. J Comp Neurol 433:101\u2013114. https:\/\/doi.org\/10.1002\/cne.1128","journal-title":"J Comp Neurol"},{"key":"1876_CR7","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1056\/nejm200008173430701","volume":"343","author":"SY Bookheimer","year":"2000","unstructured":"Bookheimer SY, Strojwas MH, Cohen MS, Saunders AM, Pericak-Vance MA, Mazziotta JC, Small GW (2000) Patterns of brain activation in people at risk for Alzheimer\u2019s disease. N Engl J Med 343:450\u2013456. https:\/\/doi.org\/10.1056\/nejm200008173430701","journal-title":"N Engl J Med"},{"key":"1876_CR8","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/s0896-6273(00)80230-5","volume":"17","author":"DR Borchelt","year":"1996","unstructured":"Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, Ratovitsky T, Prada CM, Kim G, Seekins S, Yager D et al (1996) Familial Alzheimer\u2019s disease-linked presenilin 1 variants elevate Abeta1-42\/1-40 ratio in vitro and in vivo. Neuron 17:1005\u20131013. https:\/\/doi.org\/10.1016\/s0896-6273(00)80230-5","journal-title":"Neuron"},{"key":"1876_CR9","doi-asserted-by":"publisher","first-page":"8740","DOI":"10.1073\/pnas.1206171109","volume":"109","author":"MA Busche","year":"2012","unstructured":"Busche MA, Chen X, Henning HA, Reichwald J, Staufenbiel M, Sakmann B, Konnerth A (2012) Critical role of soluble amyloid-beta for early hippocampal hyperactivity in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci USA 109:8740\u20138745. https:\/\/doi.org\/10.1073\/pnas.1206171109","journal-title":"Proc Natl Acad Sci USA"},{"key":"1876_CR10","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/0896-6273(95)90158-2","volume":"15","author":"FA Chaudhry","year":"1995","unstructured":"Chaudhry FA, Lehre KP, van Lookeren CM, Ottersen OP, Danbolt NC, Storm-Mathisen J (1995) Glutamate transporters in glial plasma membranes: highly differentiated localizations revealed by quantitative ultrastructural immunocytochemistry. Neuron 15:711\u2013720. https:\/\/doi.org\/10.1016\/0896-6273(95)90158-2","journal-title":"Neuron"},{"key":"1876_CR11","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1523\/JNEUROSCI.22-06-02142.2002","volume":"22","author":"W Chen","year":"2002","unstructured":"Chen W, Aoki C, Mahadomrongkul V, Gruber CE, Wang GJ, Blitzblau R, Irwin N, Rosenberg PA (2002) Expression of a variant form of the glutamate transporter GLT1 in neuronal cultures and in neurons and astrocytes in the rat brain. J Neurosci\u202f: Off J Socfor Neurosci 22:2142\u20132152. https:\/\/doi.org\/10.1523\/JNEUROSCI.22-06-02142.2002","journal-title":"J Neurosci : Off J Socfor Neurosci"},{"key":"1876_CR12","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.yebeh.2012.11.040","volume":"26","author":"J Chin","year":"2013","unstructured":"Chin J, Scharfman HE (2013) Shared cognitive and behavioral impairments in epilepsy and Alzheimer\u2019s disease and potential underlying mechanisms. Epilepsy Behavior\u202f: E&B 26:343\u2013351. https:\/\/doi.org\/10.1016\/j.yebeh.2012.11.040","journal-title":"Epilepsy Behavior : E&B"},{"key":"1876_CR13","first-page":"597","volume":"50","author":"W Danysz","year":"1998","unstructured":"Danysz W, Parsons CG (1998) Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications. Pharmacol Rev 50:597\u2013664","journal-title":"Pharmacol Rev"},{"key":"1876_CR14","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/19083","volume":"398","author":"B De Strooper","year":"1999","unstructured":"De Strooper B, Annaert W, Cupers P, Saftig P, Craessaerts K, Mumm JS, Schroeter EH, Schrijvers V, Wolfe MS, Ray WJ et al (1999) A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 398:518\u2013522. https:\/\/doi.org\/10.1038\/19083","journal-title":"Nature"},{"key":"1876_CR15","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1212\/01.wnl.0000171450.97464.49","volume":"65","author":"BC Dickerson","year":"2005","unstructured":"Dickerson BC, Salat DH, Greve DN, Chua EF, Rand-Giovannetti E, Rentz DM, Bertram L, Mullin K, Tanzi RE, Blacker D et al (2005) Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology 65:404\u2013411. https:\/\/doi.org\/10.1212\/01.wnl.0000171450.97464.49","journal-title":"Neurology"},{"key":"1876_CR16","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.3233\/jad-180708","volume":"66","author":"S Fan","year":"2018","unstructured":"Fan S, Xian X, Li L, Yao X, Hu Y, Zhang M, Li W (2018) ceftriaxone improves cognitive function and upregulates GLT-1-related glutamate-glutamine cycle in APP\/PS1 mice. J Alzheimer\u2019s Disease\u202f: JAD 66:1731\u20131743. https:\/\/doi.org\/10.3233\/jad-180708","journal-title":"J Alzheimer's Disease : JAD"},{"key":"1876_CR17","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.neuroscience.2008.08.043","volume":"157","author":"DN Furness","year":"2008","unstructured":"Furness DN, Dehnes Y, Akhtar AQ, Rossi DJ, Hamann M, Grutle NJ, Gundersen V, Holmseth S, Lehre KP, Ullensvang K et al (2008) A quantitative assessment of glutamate uptake into hippocampal synaptic terminals and astrocytes: new insights into a neuronal role for excitatory amino acid transporter 2 (EAAT2). Neuroscience 157:80\u201394. https:\/\/doi.org\/10.1016\/j.neuroscience.2008.08.043","journal-title":"Neuroscience"},{"key":"1876_CR18","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3389\/fnagi.2018.00122","volume":"10","author":"P Garcia-Esparcia","year":"2018","unstructured":"Garcia-Esparcia P, Diaz-Lucena D, Ainciburu M, Torrejon-Escribano B, Carmona M, Llorens F, Ferrer I (2018) Glutamate transporter GLT1 expression in Alzheimer disease and dementia with Lewy bodies. Frontiers in aging neuroscience 10:122. https:\/\/doi.org\/10.3389\/fnagi.2018.00122","journal-title":"Frontiers in aging neuroscience"},{"issue":"4438\u20134453","key":"1876_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.08.005","volume":"186","author":"V Gazestani","year":"2023","unstructured":"Gazestani V, Kamath T, Nadaf NM, Dougalis A, Burris SJ, Rooney B, Junkkari A, Vanderburg C, Pelkonen A, Gomez-Budia M et al (2023) Early Alzheimer\u2019s disease pathology in human cortex involves transient cell states. Cell 186(4438\u20134453):e4423. https:\/\/doi.org\/10.1016\/j.cell.2023.08.005","journal-title":"Cell"},{"key":"1876_CR20","doi-asserted-by":"publisher","first-page":"18275","DOI":"10.1523\/JNEUROSCI.3305-11.2011","volume":"31","author":"EN Genda","year":"2011","unstructured":"Genda EN, Jackson JG, Sheldon AL, Locke SF, Greco TM, O\u2019Donnell JC, Spruce LA, Xiao R, Guo W, Putt M et al (2011) Co-compartmentalization of the astroglial glutamate transporter, GLT-1, with glycolytic enzymes and mitochondria. J Neurosci 31:18275\u201318288. https:\/\/doi.org\/10.1523\/JNEUROSCI.3305-11.2011","journal-title":"J Neurosci"},{"key":"1876_CR21","doi-asserted-by":"publisher","first-page":"39505","DOI":"10.1074\/jbc.M408038200","volume":"279","author":"S Gendreau","year":"2004","unstructured":"Gendreau S, Voswinkel S, Torres-Salazar D, Lang N, Heidtmann H, Detro-Dassen S, Schmalzing G, Hidalgo P, Fahlke C (2004) A trimeric quaternary structure is conserved in bacterial and human glutamate transporters. J Biol Chem 279:39505\u201339512. https:\/\/doi.org\/10.1074\/jbc.M408038200","journal-title":"J Biol Chem"},{"key":"1876_CR22","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/cercor\/10.1.50","volume":"10","author":"ZH Guo","year":"2000","unstructured":"Guo ZH, Mattson MP (2000) Neurotrophic factors protect cortical synaptic terminals against amyloid and oxidative stress-induced impairment of glucose transport, glutamate transport and mitochondrial function. Cerebral cortex(New York, NY\u202f: 1991) 10:50\u201357. https:\/\/doi.org\/10.1093\/cercor\/10.1.50","journal-title":"Cerebral cortex(New York, NY : 1991)"},{"key":"1876_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116969","volume":"238","author":"N Hamidi","year":"2019","unstructured":"Hamidi N, Nozad A, Sheikhkanloui Milan H, Salari AA, Amani M (2019) Effect of ceftriaxone on paired-pulse response and long-term potentiation of hippocampal dentate gyrus neurons in rats with Alzheimer-like disease. Life Sci 238:116969. https:\/\/doi.org\/10.1016\/j.lfs.2019.116969","journal-title":"Life Sci"},{"key":"1876_CR24","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3233\/jad-142160","volume":"44","author":"KN Hascup","year":"2015","unstructured":"Hascup KN, Hascup ER (2015) Altered neurotransmission prior to cognitive decline in AbetaPP\/PS1 mice, a model of Alzheimer\u2019s disease. Journal of Alzheimer\u2019s disease\u202f: JAD 44:771\u2013776. https:\/\/doi.org\/10.3233\/jad-142160","journal-title":"Journal of Alzheimer's disease : JAD"},{"key":"1876_CR25","doi-asserted-by":"publisher","first-page":"27715","DOI":"10.1074\/jbc.271.44.27715","volume":"271","author":"O Haugeto","year":"1996","unstructured":"Haugeto O, Ullensvang K, Levy LM, Chaudhry FA, Honore T, Nielsen M, Lehre KP, Danbolt NC (1996) Brain glutamate transporter proteins form homomultimers. J Biol Chem 271:27715\u201327722. https:\/\/doi.org\/10.1074\/jbc.271.44.27715","journal-title":"J Biol Chem"},{"issue":"1898\u20131913","key":"1876_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2023.03.024","volume":"111","author":"X Hou","year":"2023","unstructured":"Hou X, Zhang X, Zou H, Guan M, Fu C, Wang W, Zhang ZR, Geng Y, Chen Y (2023) Differential and substrate-specific inhibition of gamma-secretase by the C-terminal region of ApoE2, ApoE3, and ApoE4. Neuron 111(1898\u20131913):e1895. https:\/\/doi.org\/10.1016\/j.neuron.2023.03.024","journal-title":"Neuron"},{"key":"1876_CR27","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.brainres.2017.10.011","volume":"1678","author":"S Huang","year":"2018","unstructured":"Huang S, Tong H, Lei M, Zhou M, Guo W, Li G, Tang X, Li Z, Mo M, Zhang X et al (2018) Astrocytic glutamatergic transporters are involved in Abeta-induced synaptic dysfunction. Brain Res 1678:129\u2013137. https:\/\/doi.org\/10.1016\/j.brainres.2017.10.011","journal-title":"Brain Res"},{"key":"1876_CR28","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3233\/jad-2007-11113","volume":"11","author":"CP Jacob","year":"2007","unstructured":"Jacob CP, Koutsilieri E, Bartl J, Neuen-Jacob E, Arzberger T, Zander N, Ravid R, Roggendorf W, Riederer P, Grunblatt E (2007) Alterations in expression of glutamatergic transporters and receptors in sporadic Alzheimer\u2019s disease. J Alzheimer\u2019s Disease\u202f: JAD 11:97\u2013116. https:\/\/doi.org\/10.3233\/jad-2007-11113","journal-title":"J Alzheimer's Disease : JAD"},{"key":"1876_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.eplepsyres.2017.09.006","volume":"137","author":"J Joutsa","year":"2017","unstructured":"Joutsa J, Rinne JO, Karrasch M, Hermann B, Johansson J, Anttinen A, Eskola O, Helin S, Shinnar S, Sillanpaa M (2017) Brain glucose metabolism and its relation to amyloid load in middle-aged adults with childhood-onset epilepsy. Epilepsy Res 137:69\u201372. https:\/\/doi.org\/10.1016\/j.eplepsyres.2017.09.006","journal-title":"Epilepsy Res"},{"key":"1876_CR30","doi-asserted-by":"publisher","first-page":"4714","DOI":"10.1038\/s41467-022-32442-6","volume":"13","author":"T Kato","year":"2022","unstructured":"Kato T, Kusakizako T, Jin C, Zhou X, Ohgaki R, Quan L, Xu M, Okuda S, Kobayashi K, Yamashita K et al (2022) Structural insights into inhibitory mechanism of human excitatory amino acid transporter EAAT2. Nat Commun 13:4714. https:\/\/doi.org\/10.1038\/s41467-022-32442-6","journal-title":"Nat Commun"},{"key":"1876_CR31","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1046\/j.1471-4159.1997.69010273.x","volume":"69","author":"JN Keller","year":"1997","unstructured":"Keller JN, Pang Z, Geddes JW, Begley JG, Germeyer A, Waeg G, Mattson MP (1997) Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid beta-peptide: role of the lipid peroxidation product 4-hydroxynonenal. J Neurochem 69:273\u2013284. https:\/\/doi.org\/10.1046\/j.1471-4159.1997.69010273.x","journal-title":"J Neurochem"},{"key":"1876_CR32","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41598-018-19442-7","volume":"8","author":"E Kobayashi","year":"2018","unstructured":"Kobayashi E, Nakano M, Kubota K, Himuro N, Mizoguchi S, Chikenji T, Otani M, Mizue Y, Nagaishi K, Fujimiya M (2018) Activated forms of astrocytes with higher GLT-1 expression are associated with cognitive normal subjects with Alzheimer pathology in human brain. Sci Rep 8:1712. https:\/\/doi.org\/10.1038\/s41598-018-19442-7","journal-title":"Sci Rep"},{"key":"1876_CR33","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1042\/an20130017","volume":"5","author":"M Kulijewicz-Nawrot","year":"2013","unstructured":"Kulijewicz-Nawrot M, Sykova E, Chvatal A, Verkhratsky A, Rodriguez JJ (2013) Astrocytes and glutamate homoeostasis in Alzheimer\u2019s disease: a decrease in glutamine synthetase, but not in glutamate transporter-1, in the prefrontal cortex. ASN Neuro 5:273\u2013282. https:\/\/doi.org\/10.1042\/an20130017","journal-title":"ASN Neuro"},{"key":"1876_CR34","doi-asserted-by":"crossref","unstructured":"Lakowicz JR (1999) Principles of fluorescence spectroscopy. Kluwer Academic\/Plenum, City","DOI":"10.1007\/978-1-4757-3061-6"},{"key":"1876_CR35","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/0003-2697(92)90112-k","volume":"202","author":"JR Lakowicz","year":"1992","unstructured":"Lakowicz JR, Szmacinski H, Nowaczyk K, Berndt KW, Johnson M (1992) Fluorescence lifetime imaging. Anal Biochem 202:316\u2013330. https:\/\/doi.org\/10.1016\/0003-2697(92)90112-k","journal-title":"Anal Biochem"},{"key":"1876_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0143-4160(94)90100-7","volume":"15","author":"JR Lakowicz","year":"1994","unstructured":"Lakowicz JR, Szmacinski H, Nowaczyk K, Lederer WJ, Kirby MS, Johnson ML (1994) Fluorescence lifetime imaging of intracellular calcium in COS cells using Quin-2. Cell Calcium 15:7\u201327. https:\/\/doi.org\/10.1016\/0143-4160(94)90100-7","journal-title":"Cell Calcium"},{"key":"1876_CR37","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.yebeh.2011.03.022","volume":"21","author":"AJ Larner","year":"2011","unstructured":"Larner AJ (2011) Presenilin-1 mutation Alzheimer\u2019s disease: a genetic epilepsy syndrome? Epilepsy Behavior\u202f: E&B 21:20\u201322. https:\/\/doi.org\/10.1016\/j.yebeh.2011.03.022","journal-title":"Epilepsy Behavior : E&B"},{"key":"1876_CR38","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1046\/j.1471-4159.2001.00451.x","volume":"78","author":"CM Lauderback","year":"2001","unstructured":"Lauderback CM, Hackett JM, Huang FF, Keller JN, Szweda LI, Markesbery WR, Butterfield DA (2001) The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer\u2019s disease brain: the role of Abeta1-42. J Neurochem 78:413\u2013416. https:\/\/doi.org\/10.1046\/j.1471-4159.2001.00451.x","journal-title":"J Neurochem"},{"key":"1876_CR39","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1523\/JNEUROSCI.15-03-01835.1995","volume":"15","author":"KP Lehre","year":"1995","unstructured":"Lehre KP, Levy LM, Ottersen OP, Storm-Mathisen J, Danbolt NC (1995) Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations. J Neurosci Off J Soc Neurosci 15:1835\u20131853. https:\/\/doi.org\/10.1523\/JNEUROSCI.15-03-01835.1995","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"1876_CR40","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1097\/00005072-199708000-00008","volume":"56","author":"S Li","year":"1997","unstructured":"Li S, Mallory M, Alford M, Tanaka S, Masliah E (1997) Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression. J Neuropathol Exp Neurol 56:901\u2013911. https:\/\/doi.org\/10.1097\/00005072-199708000-00008","journal-title":"J Neuropathol Exp Neurol"},{"key":"1876_CR41","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/nm1112","volume":"10","author":"A Lleo","year":"2004","unstructured":"Lleo A, Berezovska O, Herl L, Raju S, Deng A, Bacskai BJ, Frosch MP, Irizarry M, Hyman BT (2004) Nonsteroidal anti-inflammatory drugs lower Abeta42 and change presenilin 1 conformation. Nat Med 10:1065\u20131066. https:\/\/doi.org\/10.1038\/nm1112","journal-title":"Nat Med"},{"key":"1876_CR42","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/ana.410400512","volume":"40","author":"E Masliah","year":"1996","unstructured":"Masliah E, Alford M, DeTeresa R, Mallory M, Hansen L (1996) Deficient glutamate transport is associated with neurodegeneration in Alzheimer\u2019s disease. Ann Neurol 40:759\u2013766. https:\/\/doi.org\/10.1002\/ana.410400512","journal-title":"Ann Neurol"},{"key":"1876_CR43","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.neuroscience.2008.08.022","volume":"156","author":"M Matos","year":"2008","unstructured":"Matos M, Augusto E, Oliveira CR, Agostinho P (2008) Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: involvement of oxidative stress and mitogen-activated protein kinase cascades. Neuroscience 156:898\u2013910. https:\/\/doi.org\/10.1016\/j.neuroscience.2008.08.022","journal-title":"Neuroscience"},{"key":"1876_CR44","doi-asserted-by":"publisher","first-page":"4847","DOI":"10.1523\/jneurosci.0894-18.2019","volume":"39","author":"LF McNair","year":"2019","unstructured":"McNair LF, Andersen JV, Aldana BI, Hohnholt MC, Nissen JD, Sun Y, Fischer KD, Sonnewald U, Nyberg N, Webster SC et al (2019) Deletion of neuronal GLT-1 in mice reveals its role in synaptic glutamate homeostasis and mitochondrial function. J Neurosci 39:4847\u20134863. https:\/\/doi.org\/10.1523\/jneurosci.0894-18.2019","journal-title":"J Neurosci"},{"key":"1876_CR45","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1007\/s11064-020-03000-7","volume":"45","author":"LF McNair","year":"2020","unstructured":"McNair LF, Andersen JV, Nissen JD, Sun Y, Fischer KD, Hodgson NW, Du M, Aoki CJ, Waagepetersen HS, Rosenberg PA et al (2020) Conditional knockout of GLT-1 in neurons leads to alterations in aspartate homeostasis and synaptic mitochondrial metabolism in striatum and hippocampus. Neurochem Res 45:1420\u20131437. https:\/\/doi.org\/10.1007\/s11064-020-03000-7","journal-title":"Neurochem Res"},{"key":"1876_CR46","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.neurobiolaging.2018.08.002","volume":"71","author":"DJ Mi","year":"2018","unstructured":"Mi DJ, Dixit S, Warner TA, Kennard JA, Scharf DA, Kessler ES, Moore LM, Consoli DC, Bown CW, Eugene AJ et al (2018) Altered glutamate clearance in ascorbate deficient mice increases seizure susceptibility and contributes to cognitive impairment in APP\/PSEN1 mice. Neurobiol Aging 71:241\u2013254. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.08.002","journal-title":"Neurobiol Aging"},{"key":"1876_CR47","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3233\/jad-2011-110503","volume":"26","author":"P Mookherjee","year":"2011","unstructured":"Mookherjee P, Green PS, Watson GS, Marques MA, Tanaka K, Meeker KD, Meabon JS, Li N, Zhu P, Olson VG et al (2011) GLT-1 loss accelerates cognitive deficit onset in an Alzheimer\u2019s disease animal model. J of Alzheimer\u2019s Disease\u202f: JAD 26:447\u2013455. https:\/\/doi.org\/10.3233\/jad-2011-110503","journal-title":"J of Alzheimer's Disease : JAD"},{"key":"1876_CR48","doi-asserted-by":"publisher","first-page":"107559","DOI":"10.1016\/j.neuropharm.2019.03.002","volume":"161","author":"E Pajarillo","year":"2019","unstructured":"Pajarillo E, Rizor A, Lee J, Aschner M, Lee E (2019) The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: potential targets for neurotherapeutics. Neuropharmacol 161:107559. https:\/\/doi.org\/10.1016\/j.neuropharm.2019.03.002","journal-title":"Neuropharmacol"},{"key":"1876_CR49","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1001\/archneurol.2009.15","volume":"66","author":"JJ Palop","year":"2009","unstructured":"Palop JJ, Mucke L (2009) Epilepsy and cognitive impairments in Alzheimer disease. Arch Neurol 66:435\u2013440. https:\/\/doi.org\/10.1001\/archneurol.2009.15","journal-title":"Arch Neurol"},{"key":"1876_CR50","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/nrn.2016.141","volume":"17","author":"JJ Palop","year":"2016","unstructured":"Palop JJ, Mucke L (2016) Network abnormalities and interneuron dysfunction in Alzheimer disease. Nat Rev Neurosci 17:777\u2013792. https:\/\/doi.org\/10.1038\/nrn.2016.141","journal-title":"Nat Rev Neurosci"},{"key":"1876_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107172","volume":"300","author":"F Perrin","year":"2024","unstructured":"Perrin F, Sinha P, Mitchell SPC, Sadek M, Maesako M, Berezovska O (2024) Identification of PS1\/gamma-secretase and glutamate transporter GLT-1 interaction sites. J Biol Chem 300:107172. https:\/\/doi.org\/10.1016\/j.jbc.2024.107172","journal-title":"J Biol Chem"},{"key":"1876_CR52","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3389\/fnmol.2019.00164","volume":"12","author":"AR Peterson","year":"2019","unstructured":"Peterson AR, Binder DK (2019) Post-translational regulation of GLT-1 in neurological diseases and its potential as an effective therapeutic target. Front Mol Neurosci 12:164. https:\/\/doi.org\/10.3389\/fnmol.2019.00164","journal-title":"Front Mol Neurosci"},{"key":"1876_CR53","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.1523\/jneurosci.4255-14.2015","volume":"35","author":"GT Petr","year":"2015","unstructured":"Petr GT, Sun Y, Frederick NM, Zhou Y, Dhamne SC, Hameed MQ, Miranda C, Bedoya EA, Fischer KD, Armsen W et al (2015) Conditional deletion of the glutamate transporter GLT-1 reveals that astrocytic GLT-1 protects against fatal epilepsy while neuronal GLT-1 contributes significantly to glutamate uptake into synaptosomes. J Neurosci 35:5187\u20135201. https:\/\/doi.org\/10.1523\/jneurosci.4255-14.2015","journal-title":"J Neurosci"},{"key":"1876_CR54","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1007\/s11064-009-9957-0","volume":"34","author":"DV Pow","year":"2009","unstructured":"Pow DV, Cook DG (2009) Neuronal expression of splice variants of \u201cglial\u201d glutamate transporters in brains afflicted by Alzheimer\u2019s disease: unmasking an intrinsic neuronal property. Neurochem Res 34:1748\u20131757. https:\/\/doi.org\/10.1007\/s11064-009-9957-0","journal-title":"Neurochem Res"},{"key":"1876_CR55","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.3233\/JAD-190442","volume":"73","author":"O Prikhodko","year":"2020","unstructured":"Prikhodko O, Rynearson KD, Sekhon T, Mante MM, Nguyen PD, Rissman RA, Tanzi RE, Wagner SL (2020) The GSM BPN-15606 as a potential candidate for preventative therapy in Alzheimer\u2019s disease. J Alzheimer\u2019s Disease\u202f: JAD 73:1541\u20131554. https:\/\/doi.org\/10.3233\/JAD-190442","journal-title":"J Alzheimer's Disease : JAD"},{"key":"1876_CR56","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/brain\/awf001","volume":"125","author":"EA Proper","year":"2002","unstructured":"Proper EA, Hoogland G, Kappen SM, Jansen GH, Rensen MG, Schrama LH, van Veelen CW, van Rijen PC, van Nieuwenhuizen O, Gispen WH et al (2002) Distribution of glutamate transporters in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy. Brain 125:32\u201343. https:\/\/doi.org\/10.1093\/brain\/awf001","journal-title":"Brain"},{"key":"1876_CR57","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/ana.22105","volume":"68","author":"YT Quiroz","year":"2010","unstructured":"Quiroz YT, Budson AE, Celone K, Ruiz A, Newmark R, Castrillon G, Lopera F, Stern CE (2010) Hippocampal hyperactivation in presymptomatic familial Alzheimer\u2019s disease. Ann Neurol 68:865\u2013875. https:\/\/doi.org\/10.1002\/ana.22105","journal-title":"Ann Neurol"},{"key":"1876_CR58","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ebiom.2017.08.028","volume":"24","author":"F Raven","year":"2017","unstructured":"Raven F, Ward JF, Zoltowska KM, Wan Y, Bylykbashi E, Miller SJ, Shen X, Choi SH, Rynearson KD, Berezovska O et al (2017) Soluble gamma-secretase modulators attenuate Alzheimer\u2019s beta-amyloid pathology and Induce conformational changes in presenilin 1. EBioMedicine 24:93\u2013101. https:\/\/doi.org\/10.1016\/j.ebiom.2017.08.028","journal-title":"EBioMedicine"},{"key":"1876_CR59","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neuint.2016.04.010","volume":"98","author":"TS Rimmele","year":"2016","unstructured":"Rimmele TS, Rosenberg PA (2016) GLT-1: The elusive presynaptic glutamate transporter. Neurochem Int 98:19\u201328. https:\/\/doi.org\/10.1016\/j.neuint.2016.04.010","journal-title":"Neurochem Int"},{"key":"1876_CR60","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/s0896-6273(00)80086-0","volume":"16","author":"JD Rothstein","year":"1996","unstructured":"Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, Kanai Y, Hediger MA, Wang Y, Schielke JP et al (1996) Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16:675\u2013686. https:\/\/doi.org\/10.1016\/s0896-6273(00)80086-0","journal-title":"Neuron"},{"key":"1876_CR61","doi-asserted-by":"publisher","first-page":"5312","DOI":"10.1523\/jneurosci.5274-12.2013","volume":"33","author":"A Scimemi","year":"2013","unstructured":"Scimemi A, Meabon JS, Woltjer RL, Sullivan JM, Diamond JS, Cook DG (2013) Amyloid-beta1-42 slows clearance of synaptically released glutamate by mislocalizing astrocytic GLT-1. J Neurosc\u202f: Off J Soc Neurosci 33:5312\u20135318. https:\/\/doi.org\/10.1523\/jneurosci.5274-12.2013","journal-title":"J Neurosc : Off J Soc Neurosci"},{"key":"1876_CR62","doi-asserted-by":"publisher","first-page":"20195","DOI":"10.1074\/jbc.M113.471128","volume":"288","author":"R Sogaard","year":"2013","unstructured":"Sogaard R, Borre L, Braunstein TH, Madsen KL, MacAulay N (2013) Functional modulation of the glutamate transporter variant GLT1b by the PDZ domain protein PICK1. J Biol Chem 288:20195\u201320207. https:\/\/doi.org\/10.1074\/jbc.M113.471128","journal-title":"J Biol Chem"},{"key":"1876_CR63","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuron.2009.07.003","volume":"63","author":"RA Sperling","year":"2009","unstructured":"Sperling RA, Laviolette PS, O\u2019Keefe K, O\u2019Brien J, Rentz DM, Pihlajamaki M, Marshall G, Hyman BT, Selkoe DJ, Hedden T et al (2009) Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron 63:178\u2013188. https:\/\/doi.org\/10.1016\/j.neuron.2009.07.003","journal-title":"Neuron"},{"key":"1876_CR64","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1126\/science.276.5319.1699","volume":"276","author":"K Tanaka","year":"1997","unstructured":"Tanaka K, Watase K, Manabe T, Yamada K, Watanabe M, Takahashi K, Iwama H, Nishikawa T, Ichihara N, Kikuchi T et al (1997) Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science (New York, NY) 276:1699\u20131702. https:\/\/doi.org\/10.1126\/science.276.5319.1699","journal-title":"Science (New York, NY)"},{"key":"1876_CR65","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1750-3639.2002.tb00457.x","volume":"12","author":"DR Thal","year":"2002","unstructured":"Thal DR (2002) Excitatory amino acid transporter EAAT-2 in tangle-bearing Neurons in Alzheimer\u2019s disease. Brain Pathol 12:405\u2013411. https:\/\/doi.org\/10.1111\/j.1750-3639.2002.tb00457.x","journal-title":"Brain Pathol"},{"key":"1876_CR66","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1111\/j.1460-9568.1997.tb01478.x","volume":"9","author":"D Trotti","year":"1997","unstructured":"Trotti D, Rizzini BL, Rossi D, Haugeto O, Racagni G, Danbolt NC, Volterra A (1997) Neuronal and glial glutamate transporters possess an SH-based redox regulatory mechanism. Eur J Neurosci 9:1236\u20131243. https:\/\/doi.org\/10.1111\/j.1460-9568.1997.tb01478.x","journal-title":"Eur J Neurosci"},{"key":"1876_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007893","volume":"4","author":"K Uemura","year":"2009","unstructured":"Uemura K, Lill CM, Li X, Peters JA, Ivanov A, Fan Z, DeStrooper B, Bacskai BJ, Hyman BT, Berezovska O (2009) Allosteric modulation of PS1\/gamma-secretase conformation correlates with amyloid beta(42\/40) ratio. PLoS ONE 4:e7893. https:\/\/doi.org\/10.1371\/journal.pone.0007893","journal-title":"PLoS ONE"},{"key":"1876_CR68","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12753","volume":"48","author":"L Viejo","year":"2022","unstructured":"Viejo L, Noori A, Merrill E, Das S, Hyman BT, Serrano-Pozo A (2022) Systematic review of human post-mortem immunohistochemical studies and bioinformatics analyses unveil the complexity of astrocyte reaction in Alzheimer\u2019s disease. Neuropathol Appl Neurobiol 48:e12753. https:\/\/doi.org\/10.1111\/nan.12753","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1876_CR69","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neurobiolaging.2018.11.022","volume":"76","author":"J Voglein","year":"2019","unstructured":"Voglein J, Noachtar S, McDade E, Quaid KA, Salloway S, Ghetti B, Noble J, Berman S, Chhatwal J, Mori H et al (2019) Seizures as an early symptom of autosomal dominant Alzheimer\u2019s disease. Neurobiol Aging 76:18\u201323. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.11.022","journal-title":"Neurobiol Aging"},{"issue":"241","key":"1876_CR70","doi-asserted-by":"publisher","first-page":"e245","DOI":"10.1016\/j.neurobiolaging.2019.08.034","volume":"84","author":"J Voglein","year":"2019","unstructured":"Voglein J, Willem M, Trambauer J, Schonecker S, Dieterich M, Biskup S, Giudici C, Utz K, Oberstein T, Brendel M et al (2019) Identification of a rare presenilin 1 single amino acid deletion mutation (F175del) with unusual amyloid-beta processing effects. Neurobiol Aging 84(241):e245\u2013e241. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.08.034","journal-title":"Neurobiol Aging"},{"key":"1876_CR71","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1021\/bi401537v","volume":"53","author":"SL Wagner","year":"2014","unstructured":"Wagner SL, Zhang C, Cheng S, Nguyen P, Zhang X, Rynearson KD, Wang R, Li Y, Sisodia SS, Mobley WC et al (2014) Soluble gamma-secretase modulators selectively inhibit the production of the 42-amino acid amyloid beta peptide variant and augment the production of multiple carboxy-truncated amyloid beta species. Biochemistry 53:702\u2013713. https:\/\/doi.org\/10.1021\/bi401537v","journal-title":"Biochemistry"},{"key":"1876_CR72","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00401-012-1065-6","volume":"125","author":"L Wahlster","year":"2013","unstructured":"Wahlster L, Arimon M, Nasser-Ghodsi N, Post KL, Serrano-Pozo A, Uemura K, Berezovska O (2013) Presenilin-1 adopts pathogenic conformation in normal aging and in sporadic Alzheimer\u2019s disease. Acta Neuropathol 125:187\u2013199. https:\/\/doi.org\/10.1007\/s00401-012-1065-6","journal-title":"Acta Neuropathol"},{"key":"1876_CR73","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/19077","volume":"398","author":"MS Wolfe","year":"1999","unstructured":"Wolfe MS, Xia W, Ostaszewski BL, Diehl TS, Kimberly WT, Selkoe DJ (1999) Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature 398:513\u2013517. https:\/\/doi.org\/10.1038\/19077","journal-title":"Nature"},{"key":"1876_CR74","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1097\/NEN.0b013e3181e24adb","volume":"69","author":"RL Woltjer","year":"2010","unstructured":"Woltjer RL, Duerson K, Fullmer JM, Mookherjee P, Ryan AM, Montine TJ, Kaye JA, Quinn JF, Silbert L, Erten-Lyons D et al (2010) Aberrant detergent-insoluble excitatory amino acid transporter 2 accumulates in Alzheimer disease. J Neuropathol Exp Neurol 69:667\u2013676. https:\/\/doi.org\/10.1097\/NEN.0b013e3181e24adb","journal-title":"J Neuropathol Exp Neurol"},{"key":"1876_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.952096","volume":"16","author":"OWG Wood","year":"2022","unstructured":"Wood OWG, Yeung JHY, Faull RLM, Kwakowsky A (2022) EAAT2 as a therapeutic research target in Alzheimer\u2019s disease: a systematic review. Front Neurosci 16:952096. https:\/\/doi.org\/10.3389\/fnins.2022.952096","journal-title":"Front Neurosci"},{"key":"1876_CR76","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.physbeh.2016.09.018","volume":"167","author":"M Xu","year":"2016","unstructured":"Xu M, Dong Y, Wan S, Yan T, Cao J, Wu L, Bi K, Jia Y (2016) Schisantherin B ameliorates Abeta1-42-induced cognitive decline via restoration of GLT-1 in a mouse model of Alzheimer\u2019s disease. Physiol Behav 167:265\u2013273. https:\/\/doi.org\/10.1016\/j.physbeh.2016.09.018","journal-title":"Physiol Behav"},{"key":"1876_CR77","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1046\/j.1471-4159.2003.02279.x","volume":"88","author":"Y Yang","year":"2004","unstructured":"Yang Y, Kinney GA, Spain WJ, Breitner JC, Cook DG (2004) Presenilin-1 and intracellular calcium stores regulate neuronal glutamate uptake. J Neurochem 88:1361\u20131372. https:\/\/doi.org\/10.1046\/j.1471-4159.2003.02279.x","journal-title":"J Neurochem"},{"key":"1876_CR78","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/nature03018","volume":"431","author":"D Yernool","year":"2004","unstructured":"Yernool D, Boudker O, Jin Y, Gouaux E (2004) Structure of a glutamate transporter homologue from pyrococcus horikoshii. Nature 431:811\u2013818. https:\/\/doi.org\/10.1038\/nature03018","journal-title":"Nature"},{"key":"1876_CR79","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/383634a0","volume":"383","author":"N Zerangue","year":"1996","unstructured":"Zerangue N, Kavanaugh MP (1996) Flux coupling in a neuronal glutamate transporter. Nature 383:634\u2013637","journal-title":"Nature"},{"key":"1876_CR80","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1038\/s41467-022-31031-x","volume":"13","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Chen H, Geng Z, Yu Z, Li H, Dong Y, Zhang H, Huang Z, Jiang J, Zhao Y (2022) Structural basis of ligand binding modes of human EAAT2. Nat Commun 13:3329. https:\/\/doi.org\/10.1038\/s41467-022-31031-x","journal-title":"Nat Commun"},{"key":"1876_CR81","doi-asserted-by":"publisher","first-page":"8718","DOI":"10.1038\/s41598-018-26888-2","volume":"8","author":"KM Zoltowska","year":"2018","unstructured":"Zoltowska KM, Maesako M, Meier J, Berezovska O (2018) Novel interaction between Alzheimer\u2019s disease-related protein presenilin 1 and glutamate transporter 1. Sci Rep 8:8718. https:\/\/doi.org\/10.1038\/s41598-018-26888-2","journal-title":"Sci Rep"},{"key":"1876_CR82","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1126\/science.aay0198","volume":"365","author":"B Zott","year":"2019","unstructured":"Zott B, Simon MM, Hong W, Unger F, Chen-Engerer HJ, Frosch MP, Sakmann B, Walsh DM, Konnerth A (2019) A vicious cycle of beta amyloid-dependent neuronal hyperactivation. Science (New York, NY) 365:559\u2013565. https:\/\/doi.org\/10.1126\/science.aay0198","journal-title":"Science (New York, NY)"},{"key":"1876_CR83","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1016\/j.neurobiolaging.2015.04.005","volume":"36","author":"J Zumkehr","year":"2015","unstructured":"Zumkehr J, Rodriguez-Ortiz CJ, Cheng D, Kieu Z, Wai T, Hawkins C, Kilian J, Lim SL, Medeiros R, Kitazawa M (2015) Ceftriaxone ameliorates tau pathology and cognitive decline via restoration of glial glutamate transporter in a mouse model of Alzheimer\u2019s disease. Neurobiol Aging 36:2260\u20132271. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.04.005","journal-title":"Neurobiol Aging"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-024-01876-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-024-01876-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-024-01876-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T17:04:26Z","timestamp":1729530266000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-024-01876-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,21]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1876"],"URL":"https:\/\/doi.org\/10.1186\/s40478-024-01876-y","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,21]]},"assertion":[{"value":"4 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human tissue was provided by the Massachusetts Alzheimer\u2019s Disease Research Center (ADRC) with approval from the Mass General Brigham IRB (1999P009556).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no Competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"166"}}